INTECH Investment Management’s Moderna MRNA Stock Holding History

INTECH Investment Management’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$992K	Buy	19,526 +9,508	+95%	+$444K	0.01%	1025
2025 Q4	$295K	Buy	+10,018	New	+$272K	﹤0.01%	1772
2025 Q1	–	Sell	-5,956	Closed	-$248K	–	2547
2024 Q4	$248K	Buy	+5,956	New	+$285K	﹤0.01%	1927
2024 Q2	–	Sell	-330,805	Closed	-$35.3M	–	1120
2024 Q1	$35.3M	Buy	330,805 +305,609	+1,213%	+$30.8M	0.5%	40
2023 Q4	$2.51M	Sell	25,196 -77,684	-76%	-$6.53M	0.04%	310
2023 Q3	$10.6M	Sell	102,880 -233,205	-69%	-$26M	0.16%	148
2023 Q2	$40.8M	Buy	336,085 +266,888	+386%	+$35.6M	0.42%	62
2023 Q1	$10.6M	Buy	69,197 +12,599	+22%	+$2.08M	0.09%	268
2022 Q4	$10.2M	Sell	56,598 -49,423	-47%	-$8.08M	0.08%	291
2022 Q3	$12.5M	Sell	106,021 -162,236	-60%	-$24.6M	0.09%	250
2022 Q2	$38.3M	Buy	+268,257	New	+$38.3M	0.22%	127

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

INTECH Investment Management's MRNA Position: Q1 2026 in Review

INTECH Investment Management increased its Moderna (MRNA) stake by 95% in Q1 2026, buying an estimated $444K and bringing the position to 19,526 shares worth $992K. The position accounts for 0.01% of the portfolio, ranked #1025.

INTECH Investment Management first reported a position in MRNA in Q2 2022 and has held it in 11 quarters since. The position peaked at $40.8M in Q2 2023. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

INTECH Investment Management held 19,526 shares of Moderna worth $992K as of Q1 2026.
INTECH Investment Management bought 9,508 Moderna shares in Q1 2026, an estimated $444K.
Moderna made up 0.01% of INTECH Investment Management's portfolio in Q1 2026, its #1025 holding.
INTECH Investment Management first reported a position in Moderna in Q2 2022 and has held it in 11 quarters since.
INTECH Investment Management's Moderna position peaked at $40.8M in Q2 2023.
722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on INTECH Investment Management's 13F filing for Q1 2026, filed 8 May 2026.